Dr. Sarah Bergeron has experience in multidisciplinary biochemical, genetic, and cell biological approaches to determine the mechanisms of cytoskeletal mutations leading to human disease and has characterized novel biochemical properties of the two human non-muscle actin isoforms.
Courses:
CHEM 109 — General, Organic, and Biological Chemistry
CHEM 435 — Biochemistry I
CHEM 436 — Biochemistry II
CHEM 437 — Biochemistry Lab